Analysts’ Opinions Are Mixed on These Healthcare Stocks: Legend Biotech (LEGN), PROCEPT BioRobotics (PRCT) and Ginkgo Bioworks Holdings (DNA)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Legend Biotech (LEGN – Research Report), PROCEPT BioRobotics (PRCT – Research Report) and Ginkgo Bioworks Holdings (DNA – Research Report).

Legend Biotech (LEGN)

BTIG analyst Justin Zelin maintained a Buy rating on Legend Biotech yesterday and set a price target of $91.00. The company’s shares closed last Friday at $60.17.

According to TipRanks.com, Zelin is a 4-star analyst with an average return of 8.3% and a 45.9% success rate. Zelin covers the Healthcare sector, focusing on stocks such as Gracell Biotechnologies, Syndax Pharmaceuticals, and Precision BioSciences.

Currently, the analyst consensus on Legend Biotech is a Strong Buy with an average price target of $88.19, which is a 45.8% upside from current levels. In a report issued on December 22, H.C. Wainwright also reiterated a Buy rating on the stock with a $87.00 price target.

See today’s best-performing stocks on TipRanks >>

PROCEPT BioRobotics (PRCT)

In a report released yesterday, Ryan Zimmerman from BTIG maintained a Hold rating on PROCEPT BioRobotics. The company’s shares closed last Friday at $41.91, close to its 52-week high of $43.90.

According to TipRanks.com, Zimmerman is a 5-star analyst with an average return of 8.9% and a 47.5% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as GE Healthcare Technologies Inc, Tactile Systems Technology, and Treace Medical Concepts.

Currently, the analyst consensus on PROCEPT BioRobotics is a Strong Buy with an average price target of $45.14.

Ginkgo Bioworks Holdings (DNA)

In a report released yesterday, Mark Massaro from BTIG maintained a Hold rating on Ginkgo Bioworks Holdings. The company’s shares closed last Friday at $1.69.

According to TipRanks.com, Massaro is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -15.6% and a 33.0% success rate. Massaro covers the Healthcare sector, focusing on stocks such as MDxHealth S.A. Sponsored ADR, Adaptive Biotechnologies, and Castle Biosciences.

Ginkgo Bioworks Holdings has an analyst consensus of Hold, with a price target consensus of $3.67.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on LEGN:

• Legend Biotech initiated with a Sector Perform at Scotiabank
• Legend Biotech reports outcomes in CARTITUDE-4 study of CARVYKTI
• Citi opens ‘positive catalyst watch’ on Legend Biotech
• There’s an Opportunity Brewing in These 3 Stocks, Says Goldman Sachs
• Cabaletta Bio, Gracell slide as FDA probes risk of CAR T cell immunotherapies